Sequana Medical NV

Brussels Stock Exchange SEQUA.BR

Sequana Medical NV Net Income Margin for the year ending December 31, 2023: -4,572.42%

Sequana Medical NV Net Income Margin is -4,572.42% for the year ending December 31, 2023, a -37.14% change year over year. Net Income Ratio, also known as the profit margin, is the ratio of net income to net sales, showing the percentage of revenue that remains as profit after all expenses are deducted.
  • Sequana Medical NV Net Income Margin for the year ending December 31, 2022 was -3,334.08%, a 47.69% change year over year.
  • Sequana Medical NV Net Income Margin for the year ending December 31, 2021 was -6,373.84%, a -221.35% change year over year.
  • Sequana Medical NV Net Income Margin for the year ending December 31, 2020 was -1,983.45%, a -28.54% change year over year.
  • Sequana Medical NV Net Income Margin for the year ending December 31, 2019 was -1,543.05%, a -13.57% change year over year.
Key data
Date Net Income Margin EBITDA Margin EBIT Margin EBITDA
Market news
SV Wall Street
Brussels Stock Exchange: SEQUA.BR

Sequana Medical NV

CEO Mr. Ian Crosbie
IPO Date Feb. 11, 2019
Location Belgium
Headquarters Kortrijksesteenweg 1112
Employees 62
Sector Healthcare
Industries
Medical Instruments 3D Printing Biotechnology Cleaning Supplies Clinical Trials Non-Alcoholic Beverages Pharmaceuticals Pollution Treatment
Description

Sequana Medical NV, a commercial stage medical device company, engages in the development of platform for the treatment of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; Direct Sodium Removal (DSR) for the treatment of persistent congestion due to heart failure; and alfapump DSR, a fully implanted system for direct sodium removal therapy in patients with fluid overload due to heart failure. It operates in Belgium, Germany, France, Switzerland, and internationally. The company was founded in 2006 and is headquartered in Ghent, Belgium.

Similar companies

ARGX.BR

argenx SE

USD 662.53

-0.67%

StockViz Staff

February 7, 2025

Any question? Send us an email